HADLIMA PUSHTOUCH

Google image searchProduct monograph

Active ingredient

adalimumab, 40 MG/0.8 ML

DIN: 02473100

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE-DOSE AUTO-INJECTOR

Schedule: Prescription

Company: SAMSUNG BIOEPIS CO., LTD

Date: 19-FEB-2021

ATC:

Reference brand drug: Humira

Search on Google